Showing results (121-130 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|November 28, 2006
Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?Kevin J CarrollPharmaceutical Statistics|November 26, 2008
Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysisBerend Arnold Ploeger, Nicholas H G HolfordPharmaceutical Statistics|July 1, 2009
Nonparametric equivalence testing with respect to the median differenceUlrich MeierPharmaceutical Statistics|February 10, 2009
Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity scoreMasahiro SugiharaPharmaceutical Statistics|August 23, 2008
Professional development of statisticians in the pharmaceutical sector: evolution over the past decade and into the futureTrevor LewisPharmaceutical Statistics|April 2, 2009
Ratio index variables or ANCOVA? Fisher's cats revisitedYu-Kang Tu, Graham R Law, George T H Ellison, et al.Pharmaceutical Statistics|November 4, 2006
Identifying the most successful dose (MSD) in dose-finding studies in cancerSarah Zohar, John O'QuigleyPharmaceutical Statistics|November 4, 2006
Bayesian decision procedures for binary and continuous bivariate dose-escalation studiesYinghui Zhou, John Whitehead, Elisa Bonvini, et al.Pharmaceutical Statistics|November 4, 2006
Planning for an adaptive design: a case study in COPDB Jones, G Atkinson, J Ward, et al.Pharmaceutical Statistics|November 4, 2006
Implementation of a Bayesian adaptive design in a proof of concept studyMichael K Smith, Ieuan Jones, Mark F Morris, et al.Pageof 119